Clinical management of herpes simplex virus infections: past, present, and future

about

Clinical management of herpes simplex virus infections: past, present, and future

Item

http://www.wikidata.org/entity/Q59133817

description

scientific article published on 31 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Clinical management of herpes simplex virus infections: past, present, and future

@en

Clinical management of herpes simplex virus infections: past, present, and future

@nl

type

Item

label

Clinical management of herpes simplex virus infections: past, present, and future

@en

Clinical management of herpes simplex virus infections: past, present, and future

@nl

prefLabel

Clinical management of herpes simplex virus infections: past, present, and future

@en

Clinical management of herpes simplex virus infections: past, present, and future

@nl

P1476

Clinical management of herpes simplex virus infections: past, present, and future

@en

P2093

Richard Whitley

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine

Herpes simplex virus 2 ICP0 mutant viruses are avirulent and immunogenic: implications for a genital herpes vaccine

Safety and Efficacy of High-Dose Intravenous Acyclovir in the Management of Neonatal Herpes Simplex Virus Infections

Oral acyclovir suppression and neurodevelopment after neonatal herpes

New strategies against drug resistance to herpes simplex virus

Systemic gene delivery to the central nervous system using Adeno-associated virus.

Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management

Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students.

A single intramuscular vaccination of mice with the HSV-1 VC2 virus with mutations in the glycoprotein K and the membrane protein UL20 confers full protection against lethal intravaginal challenge with virulent HSV-1 and HSV-2 strains.

The nine ages of herpes simplex virus.

P304

1726

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12688/F1000RESEARCH.16157.1

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joel D Baines

P5008

ScienceSource

P577

2018-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30443341

http://www.w3.org/2001/XMLSchema#string

P921

Herpesviridae infectious disease

herpes simplex

P932

6213787

http://www.w3.org/2001/XMLSchema#string